3 best performing ASX shares in the week of 10 October 2022

Marc Kennis Marc Kennis, October 17, 2022

The 3 best performing ASX shares in the week of 3 October 2022

The 3 best performing ASX shares of the week starting 10 October 2022 were Cettire (ASX:CTT), up 46.4%, Nova Eye Medical (ASX:EYE), up 42.5%, and Element 25 (ASX:E25), up 34.2%.

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

 

1. Cettire (ASX:CTT)

Industry: Consumer Discretionary

Cettire Limited (ASX:CTT) is a global online retailer, offering a selection of in-demand personal luxury goods via its website, cettire.com. Cettire has access to a catalogue of over 1,700 luxury brands and over 190,000 products of clothing, shoes, bags and accessories.

Market Cap: $505m

12 month high / low: $0.33 – $4.81

 

Cettire

 

 

2. Nova Eye Medical (ASX:EYE)

Industry: Healthcare

Nova Eye Medical Limited (ASX:EYE, formerly Ellex Medical Lasers Limited) is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices.

Market Cap: $42m

12 month high / low: $0.18 – $0.42

 

Nova Eye Medical

 

 

3. Element 25 (ASX:E25)

Industry: Resources

Element 25 Limited (ASX:E25, formerly Montezuma Mining Company Ltd) rounds out the top 3 best performing ASX shares this week. E25 is a mineral exploration and mining company exploring for manganese, copper and gold deposits in Western Australia. The Company has a 100% interest in Yamarna Gold Project, Butcherbird Manganese-Copper Project and Green Dam Project.

Market Cap: $159m

12 month high / low: $0.425 – $2.05

 

Energy 25

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

R&D

R&D: Which companies spend the most on it and how do they set their budgets right?

R&D (Research and Development) is an important activity undertaken by ASX-listed companies of all kinds. This is most prominent in…

redox

Things were going so well for Redox (ASX:RDX), Australia’s largest chemicals importer, until its 1H25 results

It was a golden run for chemical importer Redox (ASX:RDX) from when it listed on the ASX in July 2023…until…

Growth Stocks

7 Growth Stocks to Watch This Month — Will They Beat Market Uncertainty?

Mid-way through 2025, markets remain anything but predictable. As they continue to experience volatility, investors are constantly looking for opportunities…